arrow
Back
D

David M. Schuster

 emory university

48H-index
430Paper Count
9.6KCitation Count
Published Papers 136
Publication Date
Inflammatory biomarkers have a prognostic role in patients with metastatic castration-resistant prostate cancer treated with Lutetium-177–PSMA-617
errCancer
IF5.1
err2026-04-16
err0
PREAI
errMargo B. Gerke BA; Angelo Marra MPH; Yuan Liu PhD; Akshay Bedmutha MD; Jacqueline T. Brown MD; Bassel Nazha MD; Jacob E. Berchuck MD; Ravi Bharat Parikh MD; Shahid Ahmed MD; Jordan Alana Ciuro MD; Caitlin Hartman FNP; Greta Russler McClintock FNP; Sarah Caulfield PharmD; Omer Kucuk MD; Bradley Curtis Carthon MD, PhD; David M. Schuster MD; Saima Muzahir MD; Mehmet Asim Bilen MD
errShare
errSave
Clinical outcomes of lutetium-177-PSMA-617 in a racially diverse cohort of patients with metastatic castration-resistant prostate cancer
err2026-03-01
err0
PREAI
errGerke, Margo Brooke; Bedmutha, Akshay; Marra, Angelo; Liu, Yuan; Brown, Jacqueline T.; Nazha, Bassel; Berchuck, Jacob E.; Parikh, Ravi Bharat; Ahmed, Shahid; Ciuro, Jordan Alana; Hartman, Caitlin; Mcclintock, Greta Russler; Caulfield, Sarah; Kucuk, Omer; Carthon, Bradley Curtis; Schuster, David M.; Muzahir, Saima; Bilen, Mehmet Asim
errShare
errSave
Optimizing treatment for metastatic castration-resistant prostate cancer: Food and Drug Administration-approved therapies, emerging strategies, and biomarker-driven approaches
errCancer
IF5.1
err2025-08-09
err0
PREAI
errFaisal Saeed MD; Jacob E. Berchuck MD; Mehmet Asim Bilen MD; Jatin S. Gandhi MD; Bassel Nazha MD; Jacqueline T. Brown MD; David M. Schuster MD; Ashesh B. Jani MD; Jindan Yu MD, PhD; Lara R. Harik MD
errShare
errSave
Volumetric Changes and Acute Toxicity with 68Ga Prostate-Specific Membrane Antigen vs 18F-Fluciclovine PET/CT Guided Post-Prostatectomy Radiation: Final Analysis of a Randomized Trial
err2025-07-28
err0
PREAI
errVishal R. Dhere; David M. Schuster; Subir Goyal; Eduard Schreibmann; Nikhil T. Sebastian; Sagar A. Patel; Sheela Hanasoge; Joseph W. Shelton; Pretesh R. Patel; Bruce W. Hershatter; Olayinka A. Abiodun-Ojo; Ismaheel O. Lawal; Ashesh B. Jani
errShare
errSave
Imaging poly(ADP-ribose) polymerase-1 (PARP1) in vivo with 18F-labeled brain penetrant positron emission tomography (PET) ligand
err2025-05-26
err0
errOAAI
errXin Zhou; Jiahui Chen; Jimmy S. Patel; Wenqing Ran; Yinlong Li; Richard S. Van; Mostafa M.H. Ibrahim; Chunyu Zhao; Yabiao Gao; Jian Rong; Ahmad F. Chaudhary; Guocong Li; Junqi Hu; April T. Davenport; James B. Daunais; Yihan Shao; Chongzhao Ran; Thomas L. Collier; Achi Haider; David M. Schuster; Allan I. Levey; Lu Wang; Gabriel Corfas; Steven H. Liang
errShare
errSave
Detection Rates of PSMA-PET Radiopharmaceuticals in Recurrent Prostate Cancer: A Systematic Review
err2025-05-13
err0
errOAAI
errRais-Bahrami, Soroush; Davis, Phillip; Chau, Albert; Galgano, Samuel J.; Chapin, Brian F.; Schuster, David M.; Turnbull, Catriona M.
errShare
errSave
Diuresis During 18F-Flotufolastat (rhPSMA-7.3) PET/CT Improves Recurrence Detection After Prostatectomy: A Prospective Phase II Trial
err2025-01-23
err0
PREAI
errLawal, Ismaheel O.; Mushtaq, Aliza; Jani, Ashesh B.; Rupji, Manali; Dhere, Vishal R.; Patel, Sagar A.; Bilen, Mehmet A.; Patel, Pretesh R.; Sebastian, Nikhil T.; Switchenko, Jeffrey M.; Schuster, David M.; Marcus, Charles
errShare
errSave
Prospective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinoma
err2024-07-08
err1
PREAI
errMushtaq, Aliza; Lawal, Ismaheel O.; Muzahir, Saima; Friend, Sarah C.; Bhave, Manali; Meisel, Jane L.; Torres, Mylin A.; Styblo, Toncred M.; Graham, Cathy L.; Kalinsky, Kevin; Switchenko, Jeffrey; Ulaner, Gary Allan; Schuster, David M.
errShare
errSave
Interreader and Intrareader Reproducibility of 18F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies
err2024-06-13
err0
errOAAI
errKuo, Phillip H.; Esposito, Giuseppe; Ulaner, Gary A.; Yoo, Don; Zukotynski, Katherine; Ravizzini, Gregory C.; Penny, Ross; Miller, Matthew P.; Chau, Albert; Davis, Phillip; Chapin, Brian F.; Schuster, David M.
errShare
errSave
errShare
errSave
Resin-Based 90Y Tumor Dose as a Predictor of Duration of Response and Survival in Patients With Surgically Unresectable Hepatocellular Carcinoma
err2024-05-21
err0
errOAAI
errKokabi, Nima; Webster, Linzi A.; Dabbous, Howard; Shah, Anand; Brandon, David; Galt, James; Xing, Minzhi; Villalobos, Alexander; Davarpanahfakhr, Amir; Kappadath, S. Cheenu; Schuster, David M.
errShare
errSave
A Phase II Multi-Institutional Study of Concurrent Radiotherapy, Palbociclib, and HormoneTherapy for Treatment of Bone Metastasis in Breast Cancer Patients
err2024-05-02
err0
PREAI
errTorres, Mylin; Lin, Jolinta; Friend, Sarah; Xiao, Canhua; Cao, Yichun; Kahn, Shannon; Godette, Karen; Hanasoge, Sheela; Yu, David; Eng, Tony; Cheney, Matthew; Wiggers, Nancy; Pippas, Andrew; Gogineni, Keerthi; Meisel, Jane; Schuster, David; Bardia, Aditya; Miller, Andrew; Felger, Jennifer; Switchenko, Jeffrey; Zelnak, Amelia; Kalinsky, Kevin; Bhave, Manali
errShare
errSave
Lesion segmentation on 18F-fluciclovine PET/CT images using deep learning
err2023-12-13
err4
errOAAI
errWang, Tonghe; Lei, Yang; Schreibmann, Eduard; Roper, Justin; Liu, Tian; Schuster, David M.; Jani, Ashesh B.; Yang, Xiaofeng
errShare
errSave
Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)
err2023-10-01
err34
errOAAI
errSurasi, Devaki Shilpa; Eiber, Matthias; Maurer, Tobias; Preston, Mark A.; Helfand, Brian T.; Josephson, David; Tewari, Ashutosh K.; Somford, Diederik M.; Rais-Bahrami, Soroush; Koontz, Bridget F.; Bostrom, Peter J.; Chau, Albert; Davis, Phillip; Schuster, David M.
errShare
errSave
Evaluation of Treatment Response in Patients with Breast Cancer
err2023-10-01
err3
PREAI
errMuzahir, Saima; Ulaner, Gary A.; Schuster, David M.
errShare
errSave
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply.
err2023-09-01
err7
PREAI
errJani, Ashesh B.; Ravizzini, Gregory C.; Gartrell, Benjamin A.; Siegel, Barry A.; Twardowski, Przemyslaw; Saltzstein, Daniel; Fleming, Mark T.; Chau, Albert; Davis, Phillip; Chapin, Brian F.; Schuster, David M.
errShare
errSave
Stronger Together-Collaboration Will Only Enhance Patient Care
err2023-08-10
err1
errOAAI
errGrady, Erin E.; Mankoff, David A.; Schuster, David M.
errShare
errSave
Reply by Authors
err2023-08-01
err0
PREAI
errJani, Ashesh B.; Ravizzini, Gregory C.; Gartrell, Benjamin A.; Siegel, Barry A.; Twardowski, Przemyslaw; Saltzstein, Daniel; Fleming, Mark T.; Chau, Albert; Davis, Phillip; Chapin, Brian F.; Schuster, David M.
errShare
errSave
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)
err2023-08-01
err36
errOAAI
errJani, Ashesh B.; Ravizzini, Gregory C.; Gartrell, Benjamin A.; Siegel, Barry A.; Twardowski, Przemyslaw; Saltzstein, Daniel; Fleming, Mark T.; Chau, Albert; Davis, Phillip; Chapin, Brian F.; Schuster, David M.
errShare
errSave